GCP-certified clinical research professional specializing in Japanese–English medical translation, US–Japan pharmaceutical consulting, and in vitro diagnostic device trial support. Serving pharmaceutical, biotechnology, and IVD organizations across US and Japan markets.
A protocol means nothing if the cultural weight behind it is lost. A consent form is not just a legal document - it is a conversation. At Kakehashi Clinical, we work in the space where clinical precision and cultural fluency are not traded off against each other. They are the same thing.
Every service I offer sits at the intersection of clinical science, Japanese language, and cross-border operations across drug and device clinical research. I work directly with you on every project - no handoffs, no agencies.
Kakehashi Clinical works with organizations where the distance between US and Japanese clinical research systems creates friction. That friction is where we operate.
Unlike general translators, I bring a biology degree and active GCP-compliant clinical trial experience to every document. Scientific precision and linguistic fluency - together.
Pharma, biotech, IVD manufacturers, and CRO teams working across US and Japanese markets who need translation that is scientifically accurate, not just linguistically correct.
Specialized support for Japanese pharma and device companies operating in the U.S., and U.S. organizations working with Japanese sponsors or sites. Spanning both drug and device clinical research, including in vitro diagnostic trials regulated under ISO 14155 and FDA 21 CFR Part 820 frameworks, with direct experience in ISO 13485-regulated IVD product environments. For Japanese pharmaceutical and device organizations, this includes orientation to structural differences between FDA and PMDA regulatory frameworks - critical context for cross-border trial planning and document preparation.
Japanese pharmaceutical, medical device, and IVD companies entering the U.S. clinical trial space, or U.S. research organizations whose sites, sponsors, or documentation involve the Japanese market.
Expanding into a new market means more than translation - it means understanding how the audience thinks, what they trust, and what builds credibility. I bring both the science and the cultural fluency.
Biotech and health brands expanding into the U.S. or Japanese market for the first time, who need someone with genuine scientific credibility and bilingual fluency.
Regulatory documentation is the backbone of every compliant operation. Whether you need existing SOPs translated between English and Japanese, new SOPs drafted for a regulated environment, or quality documentation prepared for cross-border review, this service delivers precise, audit-ready output grounded in real regulated-environment experience across GCP, GMP, and ISO-based quality systems.
Biotech startups building out their quality systems. Clinical sites preparing for sponsor or regulatory audit. Japanese organizations entering US operations who need English-language SOPs. US organizations with Japanese partners requiring bilingual documentation. Small CROs without dedicated regulatory writing staff.
I'm Chadwin Bush - a GCP-certified clinical research professional with deep scientific training, experience supporting ISO 13485, GMP, and ISO-classified cleanroom operations, and advanced professional Japanese fluency built entirely through self-study and immersion.
I didn't take a class. I didn't use a tutor. I built my Japanese proficiency entirely through self-directed study - daily vocabulary review, immersive media, and real conversation with native speakers. Scoring in the 98.1st percentile on the JLPT N2 - with a perfect 60/60 on the listening section - is proof that consistency over time produces extraordinary results.
That same discipline carries into my scientific work. That experience spans four distinct regulated environments: GCP-governed clinical trial operations, ISO 13485 and GMP-regulated in vitro diagnostic product testing, ISO-classified cleanroom tissue processing, and aseptic biological manufacturing. Each environment demanded precision, documentation rigor, and zero-margin-for-error standards.
I founded Kakehashi Clinical because I saw a gap very few people can fill: the space between U.S. clinical research operations and the Japanese pharmaceutical market. When you work with me, you work with me directly. I am personally accountable for every deliverable.
I am currently pursuing JLPT N1 through daily study - the highest level of Japanese language certification - and remain actively embedded in clinical trial operations.
Japanese is not just a language I studied. It is a culture I fell into, friendships that became family, a way of seeing the world that changed how I think about communication itself. 空気を読む - reading the atmosphere, understanding what is implied but left unsaid - is not a translation technique. It is a way of being present. That is what I bring to every document, every consultation, every client relationship. Translation that is only word-for-word is not translation. It is transcription. True translation carries the nuance, the implication, the meaning between the lines - the purple that emerges when two distinct worlds are allowed to meet.
Perform comprehensive secondary screening to evaluate patient eligibility, reviewing medical history and applying protocol inclusion/exclusion criteria to ensure high-quality referrals. Coordinate with site staff and investigators to support enrollment targets and maintain GCP-compliant documentation across all screening activities. Experience encompasses both drug and device clinical trial operations.
Performed microbiological testing on raw materials and finished products ensuring quality and safety compliance. Maintained strict aseptic technique, accurate documentation, and adherence to GMP and ISO standards.
Performed aseptic processing of human tissues and autologous serum eye drops (ASED) in a controlled cleanroom environment under strict SOP and regulatory compliance. Coordinated specimen collection workflows including phlebotomy, labeling, and documentation ensuring full traceability.
Worked fully embedded in a Japanese company in Shibuya, Tokyo - operating entirely in Japanese in a professional setting. Managed social media platforms, developed content strategy, and increased engagement 10x in the first week. Built lasting professional relationships with Japanese colleagues.
Conducted regulated testing of raw materials and in vitro diagnostic finished products under ISO 13485 and GMP guidelines in an environment subject to FDA and international regulatory inspection. IVD finished product testing in an FDA and internationally regulated environment, including audit-ready documentation and BSL-2 agent handling. Documented and reviewed laboratory data supporting audit readiness and regulatory inspections. Applied biochemistry experience and BSL-2 agent handling to validate product integrity.
Minor in Healthcare Administration. Coursework spanning microbiology, biochemistry, human anatomy, physiology, and healthcare systems. Foundation for all subsequent regulated scientific work.
Whether you need a document translated, a protocol reviewed, or an ongoing consulting partner for your US–Japan operations - I respond to all inquiries within one business day.